Kiniksa Pharmaceuticals International, plc (KNSA) stock
KNSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 14/30461% above fair value
$94.23−2.10 (-2.18%)
Close on Nov 16, 2026Market cap $14.81BP/E 72.5Yield –
Kiniksa Pharmaceuticals International operating margin
Operating margin is operating income as a percentage of revenue.
Kiniksa Pharmaceuticals International's operating margin for the twelve months ending Sep 30, 2026 was 13.8%. For fiscal 2025 it was 11.4%, against -10.8% the year before. The highest annual figure on record is 11.4% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11.4% | +22.2 |
| FY2024 | Dec 31, 2024 | -10.8% | −1.5 |
| FY2023 | Dec 31, 2023 | -9.3% | −13.8 |
| FY2022 | Dec 31, 2022 | 4.4% | +410.8 |
| FY2021 | Dec 31, 2021 | -406.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 19.0% | +5.7 |
| Q2 FY2026 | Jun 30, 2026 | 11.2% | −1.7 |
| Q1 FY2026 | Mar 31, 2026 | 13.7% | +4.0 |
| Q4 FY2025 | Dec 31, 2025 | 9.8% | +25.5 |
| Q3 FY2025 | Sep 30, 2025 | 13.3% | +21.9 |
| Q2 FY2025 | Jun 30, 2025 | 12.9% | +13.0 |
| Q1 FY2025 | Mar 31, 2025 | 9.6% | +30.3 |
| Q4 FY2024 | Dec 31, 2024 | -15.7% | −15.8 |
| Q3 FY2024 | Sep 30, 2024 | -8.6% | +7.7 |
| Q2 FY2024 | Jun 30, 2024 | -0.1% | +4.3 |
| Q1 FY2024 | Mar 31, 2024 | -20.7% | +2.4 |
| Q4 FY2023 | Dec 31, 2023 | 0.1% | −9.7 |
| Q3 FY2023 | Sep 30, 2023 | -16.3% | −63.1 |
| Q2 FY2023 | Jun 30, 2023 | -4.4% | +67.4 |
| Q1 FY2023 | Mar 31, 2023 | -23.2% | +49.3 |
| Q4 FY2022 | Dec 31, 2022 | 9.8% | +202.5 |
| Q3 FY2022 | Sep 30, 2022 | 46.8% | +300.4 |
| Q2 FY2022 | Jun 30, 2022 | -71.8% | +454.6 |
| Q1 FY2022 | Mar 31, 2022 | -72.4% | – |
| Q4 FY2021 | Dec 31, 2021 | -192.8% | – |
| Q3 FY2021 | Sep 30, 2021 | -253.6% | – |
| Q2 FY2021 | Jun 30, 2021 | -526.4% | – |
See a number that looks wrong?